SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-06-19
👔
Lyell Immunopharma, Inc.
@LYEL_InsiderForm 4 Filing: Innovative Cellular Therapeutics Holdings Ltd Acquires shares of $LYEL
INSIDER TRANSACTION
⚡ MATERIALITY: 1/10
corporate issuer
Lyell Immunopharma, Inc.
Ticker: $LYEL
Transaction Value
N/A (Non-Open-Market)
Price/Share: $0.00 (Non-Open-Market)
transaction date
2026-06-15
Shares: 66,500
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Innovative Cellular Therapeutics Holdings Ltd, holds the title of 10% Owner at Lyell Immunopharma, Inc..
On 2026-06-15, the insider transacted 66,500 shares.This transaction is a non-open-market event (such as a stock grant or option exercise) with a reported price per share of $0.00.
Executive Summary Summary
Innovative Cellular Therapeutics Holdings Ltd (10% Owner) transacted $0 of $LYEL
Post-Transaction Position: 2,933,500 shares
SEC Accession No: 0001140361-26-025796 (CIK: 2095697)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.